LC
RGEN icon

Lindbrook Capital’s Repligen RGEN Stock Holding History

Lindbrook Capital’s Portfolio RGEN Stock Details RGEN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		$18.7K Sell
147
-8
-5% -$1.23K ﹤0.01% 1384
2024
Q4 		$22.3K Sell
155
-16
-9% -$2.29K ﹤0.01% 1223
2024
Q3 		$25.4K Buy
171
+119
+229% +$17.1K ﹤0.01% 1161
2024
Q2 		$6.55K Sell
52
-68
-57% -$10.7K ﹤0.01% 1865
2024
Q1 		$22.1K Buy
120
+3
+3% +$571 ﹤0.01% 1158
2023
Q4 		$21K Buy
117
+62
+113% +$9.65K ﹤0.01% 1150
2023
Q3 		$8.75K Sell
55
-2
-4% -$327 ﹤0.01% 1483
2023
Q2 		$8.06K Sell
57
-3
-5% -$481 ﹤0.01% 1591
2023
Q1 		$10.1K Buy
60
+21
+54% +$3.75K ﹤0.01% 1447
2022
Q4 		$6.6K Sell
39
-22
-36% -$3.99K ﹤0.01% 1659
2022
Q3 		$11K Buy
61
+29
+91% +$6.12K ﹤0.01% 1291
2022
Q2 		$5K Sell
32
-43
-57% -$6.8K ﹤0.01% 1566
2022
Q1 		$14K Sell
75
-59
-44% -$11.2K ﹤0.01% 1163
2021
Q4 		$35K Buy
134
+20
+18% +$5.39K 0.01% 838
2021
Q3 		$33K Buy
114
+1
+0.9% +$257 0.01% 570
2021
Q2 		$23K Sell
113
-6
-5% -$1.16K 0.01% 735
2021
Q1 		$23K Buy
119
+14
+13% +$2.87K 0.01% 705
2020
Q4 		$20K Buy
105
+65
+163% +$11.8K ﹤0.01% 687
2020
Q3 		$6K Buy
40
+19
+90% +$2.72K ﹤0.01% 1047
2020
Q2 		$3K Hold
21
– – ﹤0.01% 1291
2020
Q1 		$2K Hold
21
– – ﹤0.01% 1329
2019
Q4 		$2K Hold
21
– – ﹤0.01% 1313
2019
Q3 		$2K Hold
21
– – ﹤0.01% 1292
2019
Q2 		$1K Hold
21
– – ﹤0.01% 1346
2019
Q1 		$1K Hold
21
– – ﹤0.01% 1331
2018
Q4 		$1K Buy
+21
New +$1.23K ﹤0.01% 1289

Other funds holding RGEN

T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
CIP
Champlain Investment Partners Burlington, Vermont $7.88B AUM 6.82% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $618B AUM 30.34% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return

Lindbrook Capital's RGEN Position: Q1 2025 in Review

Lindbrook Capital reduced its Repligen (RGEN) stake by 5.2% in Q1 2025, selling an estimated $1.23K and leaving 147 shares worth $18.7K. The position accounts for ﹤0.01% of the portfolio, ranked #1384.

Lindbrook Capital first reported a position in RGEN in Q4 2018 and has held it in 26 quarters since. The position peaked at $35K in Q4 2021. 442 funds tracked by Wall St. Rank hold RGEN as of Q1 2025.

  • Lindbrook Capital held 147 shares of Repligen worth $18.7K as of Q1 2025.
  • Lindbrook Capital sold 8 Repligen shares in Q1 2025, an estimated $1.23K.
  • Repligen made up ﹤0.01% of Lindbrook Capital's portfolio in Q1 2025, its #1384 holding.
  • Lindbrook Capital first reported a position in Repligen in Q4 2018 and has held it in 26 quarters since.
  • Lindbrook Capital's Repligen position peaked at $35K in Q4 2021.
  • 442 funds tracked by Wall St. Rank held Repligen as of Q1 2025.

Based on Lindbrook Capital's 13F filing for Q1 2025, filed 5 May 2025.